Dasatinib efficacy and tolerance in the treatment of chronic myeloid leukemia (CML) patients resistant/intolerant to imatinib in the context of real clinical practice management
ŽÁČKOVÁ, Daniela; Hana KLAMOVÁ; J. MUŽÍK; Eduard CMUNT; Blanka DOBEŠOVÁ et al.
Dasatinib efficacy and tolerance in the treatment of chronic myeloid leukemia (CML) patients resistant/intolerant to imatinib in the context of real clinical practice management
Autoři
ŽÁČKOVÁ, Daniela; Hana KLAMOVÁ; J. MUŽÍK; Eduard CMUNT; Blanka DOBEŠOVÁ; Jaroslava RYŠAVÁ; Zdeněk RÁČIL; Kateřina MACHOVÁ POLÁKOVÁ; Dana DVOŘÁKOVÁ; Tomáš JURČEK; Filip RÁZGA; J. MORAVCOVÁ; Michael DOUBEK; Alexandra OLTOVÁ; J. BŘEZINOVÁ; Petr CETKOVSKÝ; Marek TRNĚNÝ; Ladislav DUŠEK a Jiří MAYER
Vydání
16th Congress of the European Hematology Association in Haematologica - the hematology journal, 2011
ŽÁČKOVÁ, Daniela; Hana KLAMOVÁ; J. MUŽÍK; Eduard CMUNT; Blanka DOBEŠOVÁ; Jaroslava RYŠAVÁ; Zdeněk RÁČIL; Kateřina MACHOVÁ POLÁKOVÁ; Dana DVOŘÁKOVÁ; Tomáš JURČEK; Filip RÁZGA; J. MORAVCOVÁ; Michael DOUBEK; Alexandra OLTOVÁ; J. BŘEZINOVÁ; Petr CETKOVSKÝ; Marek TRNĚNÝ; Ladislav DUŠEK a Jiří MAYER. Dasatinib efficacy and tolerance in the treatment of chronic myeloid leukemia (CML) patients resistant/intolerant to imatinib in the context of real clinical practice management. In 16th Congress of the European Hematology Association in Haematologica - the hematology journal. 2011. ISSN 0390-6078.
@proceedings{960301, author = {Žáčková, Daniela and Klamová, Hana and Mužík, J. and Cmunt, Eduard and Dobešová, Blanka and Ryšavá, Jaroslava and Ráčil, Zdeněk and Machová Poláková, Kateřina and Dvořáková, Dana and Jurček, Tomáš and Rázga, Filip and Moravcová, J. and Doubek, Michael and Oltová, Alexandra and Březinová, J. and Cetkovský, Petr and Trněný, Marek and Dušek, Ladislav and Mayer, Jiří}, booktitle = {16th Congress of the European Hematology Association in Haematologica - the hematology journal}, title = {Dasatinib efficacy and tolerance in the treatment of chronic myeloid leukemia (CML) patients resistant/intolerant to imatinib in the context of real clinical practice management}, year = {2011} }
TY - CONF ID - 960301 AU - Žáčková, Daniela - Klamová, Hana - Mužík, J. - Cmunt, Eduard - Dobešová, Blanka - Ryšavá, Jaroslava - Ráčil, Zdeněk - Machová Poláková, Kateřina - Dvořáková, Dana - Jurček, Tomáš - Rázga, Filip - Moravcová, J. - Doubek, Michael - Oltová, Alexandra - Březinová, J. - Cetkovský, Petr - Trněný, Marek - Dušek, Ladislav - Mayer, Jiří PY - 2011 TI - Dasatinib efficacy and tolerance in the treatment of chronic myeloid leukemia (CML) patients resistant/intolerant to imatinib in the context of real clinical practice management ER -
ŽÁČKOVÁ, Daniela; Hana KLAMOVÁ; J. MUŽÍK; Eduard CMUNT; Blanka DOBEŠOVÁ; Jaroslava RYŠAVÁ; Zdeněk RÁČIL; Kateřina MACHOVÁ POLÁKOVÁ; Dana DVOŘÁKOVÁ; Tomáš JURČEK; Filip RÁZGA; J. MORAVCOVÁ; Michael DOUBEK; Alexandra OLTOVÁ; J. BŘEZINOVÁ; Petr CETKOVSKÝ; Marek TRNĚNÝ; Ladislav DUŠEK a Jiří MAYER. Dasatinib efficacy and tolerance in the treatment of chronic myeloid leukemia (CML) patients resistant/intolerant to imatinib in the context of real clinical practice management. In \textit{16th Congress of the European Hematology Association in Haematologica - the hematology journal}. 2011. ISSN~0390-6078.